Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-01-12

Clinical Trial Update: Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN® [Phase 4]

View source ↗

Summary

Phase 4 trial update for outpatient physical therapy in Parkinson's Disease patients currently using APOKYN; the study was terminated with results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Apokyn (apomorphine)

Snippet

Sponsor: MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals | Conditions: Parkinson's Disease, Motor Symptoms | Phase 4 | Status: TERMINATED | Results posted: 2018-01-12